Literature DB >> 11240710

Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review.

P. C. Ramos1, D. S. Kapp, T. A. Longacre, N. N. H. Teng.   

Abstract

Granular cell tumors are uncommon soft tissue tumors. Although the majority of these tumors are benign, a rare malignant variant exists which is aggressive, with local recurrence rates up to 70% and 3-year survival rates of less than 50%. We present a case of malignant granular cell tumor of the vulva in a 17-year-old, the sixth such case to be reported at this site. She was treated with a left hemivulvectomy and ipsilateral groin node dissection followed by postoperative radiation therapy. She remains free of disease at 16 months. Patients with malignant granular cell tumor or granular cell tumor of malignant potential are best managed with wide local excision and regional lymph node dissection.

Entities:  

Year:  2000        PMID: 11240710     DOI: 10.1046/j.1525-1438.2000.010005429.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

Review 1.  Solitary, multiple, benign, atypical, or malignant: the "Granular Cell Tumor" puzzle.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

2.  Granular Cell Tumors on Unusual Anatomic Locations.

Authors:  Hee Joo Kim; Min-Geol Lee
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

3.  Adjuvant radiation therapy for malignant Abrikossoff's tumor: a case report about a femoral triangle localisation.

Authors:  C Marchand Crety; C Garbar; G Madelis; F Guillemin; P Soibinet Oudot; J C Eymard; S Servagi Vernat
Journal:  Radiat Oncol       Date:  2018-06-20       Impact factor: 3.481

Review 4.  Granular cell tumor of the appendix: a case report and literature review.

Authors:  Xing Lv; Xiaodong Sun; Jianpeng Zhou; Yang Zhang; Guoyue Lv
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.